Study of the impact of the Flash Glucose Monitoring System(FGM) on glycometabolism of type 2 diabetic patients
Not Applicable
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000026452
- Lead Sponsor
- agoya University
- Brief Summary
The mean HbA1c levels were 7.83% in the FGM group and 7.84% in the SMBG group at baseline, and the values were reduced in both FGM (-0.43%) and SMBG groups (-0.30%) at 12 weeks. On the other hand, HbA1c was significantly decreased from baseline values in the FGM group, but not in the SMBG group at 24 weeks (FGM, -0.46% SMBG, -0.17%);a significant between-group difference was also observed (difference -0.29%).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Diabetic nephropathy (eGFR<30ml/min/1.73m2) Dialysis patient Receiving insulin therapy Proliferative diabetic retinopathy or preproliferative retinopathy Subjects who can not properly operate the device to be used
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method